CorMedix Inc.
CRMD
$8.65
$0.111.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 175.33% | -87.09% | 447.52% | -3.95% | 53.32% |
| Total Depreciation and Amortization | 1.06% | 175.26% | 2,226.89% | 0.56% | 20.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.05% | 170.49% | -2,160.65% | -23.57% | 159.00% |
| Change in Net Operating Assets | -208.21% | 217.91% | -451.83% | 257.98% | 77.58% |
| Cash from Operations | -55.13% | 206.13% | 2.88% | 51.96% | 451.51% |
| Capital Expenditure | 57.62% | -240.08% | -2,016.32% | -139.00% | 0.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.48% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 4.76% | -81.62% | 195.04% | -10,812.32% | 37.01% |
| Cash from Investing | -10.07% | 101.13% | -1,341.34% | -10,265.03% | 35.83% |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | 2.74% | -182.11% | -- | -- | -- |
| Issuance of Common Stock | -74.47% | 248.17% | -98.41% | 1,073.93% | -37.28% |
| Repurchase of Common Stock | -4,802.49% | 44.54% | -87.52% | 75.71% | -1,808.24% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 90.74% | -1,895.61% | -- | -- | -- |
| Cash from Financing | -756.06% | -100.94% | 80.83% | 1,266.19% | -46.01% |
| Foreign Exchange rate Adjustments | -- | -533.33% | -62.50% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -65.49% | 187.64% | -218.18% | 262.88% | 377.82% |